Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 120,257	$ 44,976
General and administrative	47,075	16,992
Total operating expenses	167,332	61,968
Loss from operations	(167,332)	(61,968)
Other income:
Other income, net	271	140
Total other income	271	140
Loss before income taxes	(167,061)	(61,828)
Benefit from income taxes	0	8
Net loss	(167,061)	(61,820)
Accretion and cumulative dividends on redeemable convertible preferred stock	0	(8,996)
Gain on repurchase of redeemable convertible preferred stock	0	493
Net loss attributable to common stockholders	$ (167,061)	$ (70,323)
Net loss per share attributable to common stockholders, basic (in usd per share)	$ (3.94)	$ (7.86)
Net loss per share attributable to common stockholders, diluted (in usd per share)	$ (3.94)	$ (7.86)
Weighted average common shares outstanding, basic (in shares)	42,454,055	8,950,152
Weighted average common shares outstanding, diluted (in shares)	42,454,055	8,950,152